Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group

NCT: NCT07235592 · RECRUITING

NCT IDNCT07235592
StatusRECRUITING
Start Date2026-03-19
Completion2027-09

Brief Summary

The purpose of this study is to collect safety and performance data on the PRESERFLO™ MicroShunt XI in patients diagnosed with primary open angle glaucoma who are inadequately controlled on maximum tolerated medical therapy with intraocular pressure ≥18 mmHg and ≤35 mmHg and/or where glaucoma progression warrants surgery.

Frequently Asked Questions

What is PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group?

PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group is a clinical trial registered under NCT07235592. Current status: RECRUITING.

What is the status of NCT07235592?

The current status of NCT07235592 (PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group) is: RECRUITING.

When did PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group start?

PRESERFLO™ MicroShunt XI Observational PMCF Study With no Control Group started on 2026-03-19.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑